Apremilast (Otezla) is an oral anti-inflammatory drug that is approved by the Food and Drug Administration (FDA) for plaque psoriasis and psoriatic arthritis (FDA 2014
It has been widely studied in controlled laboratory research settings for its involvement in neuroregulatory pathways, peptide-mediated signaling mechanisms, and various biological processes related to cellular and molecular regulation
For diagnosed deficiency, weekly for 6 to 8 weeks, then biweekly, then monthly maintenance based on follow-up labs
Refrigeration is mandatory after reconstitution Store reconstituted retatrutide at 2 to 8 degrees Celsius immediately after mixing
However, certain medications can affect B12 absorption, including metformin (used for diabetes), proton pump inhibitors, H2-receptor antagonists, and colchicine
Drug-induced liver disease